You Searched For "CRISPR" and got 20 results
Sort By:
Doctors use gene-editing to try and cure blindness for the very first time
It’s too early to determine whether the treatment is working or not. The doctors estimate that…
Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first human trials
Intellia partnered with Regeneron in 2016 to advance the CRISPR technology for in vivo therapeutic …
Matthew Fox
Cathie Wood's Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trials
Ark Invest's Cathie Wood said last year that the next "FANG" stocks would likely come from the gene…
Matthew Fox
We'll be eating the first Crispr'd foods within 5 years, according to a geneticist who helped invent the blockbuster gene-editing tool
Back in 2016, researchers at Penn State used Crispr to make mushrooms that don't brown. Last spring…
Erin Brodwin
For the first time, the USDA said it won't subject a crop edited with controversial gene-editing tool CRISPR to the same rules as GMOs
"Since its 2013 demonstration as a genome editing tool in Arabidopsis and tobacco - two widely used…
Erin Brodwin
Intellia CEO: There won't be a 'next CRISPR'
CRISPR-Cas9 is a tool that that's often described as a kind of genetic scissors. It allows scientis…
Lydia Ramsey
A major gene-editing company just inked a $335-million deal with Bayer
In October, CRISPR Therapeutics made a $105 million deal with Vertex Pharmaceutials, a partnership …
Lydia Ramsey
A troubling link has been found between a cutting-edge gene-editing technology and cancer - and it's sending biotech stocks tumbling
The CEO of CRISPR Therapeutics said in a comment to STAT News that while the results are plausible,…
Charlotte Hu
A blockbuster gene-editing tool just got one step closer to overtaking GMOs
Those companies include small ventures like Synthego, a Silicon Valley-based startup that aims to i…
Erin Brodwin
Silicon Valley startups are experimenting with gene-editing tool Crispr to help grow chicken, beef, and pork in labs - and to upend a $200 billion industry
Several bespoke food and agricultural organizations are interested in resurrecting ancient animal s…
Erin Brodwin
A medical diagnostics startup that wants to use CRISPR technology to detect diseases just raised $23 million in venture funding
Martin said that these guide-RNAs can be programmed to find disease-specific RNA or DNA sequences. …
Charlotte Hu
The world's 4th-largest chemical giant wants to genetically modify corn to create a new super crop in the next 5 years
This could be good news given Americans' hefty - though scientifically unfounded - opposition to GM…
Erin Brodwin
A blockbuster gene-editing tool has been 'linked' to cancer - here's how worried you should be
Earlier this week, reports linking the blockbuster gene-editing tool CRISPR to cancer in two stud…
Erin Brodwin
ICMR's regional centre develops technology that can test for tuberculosis in just Rupees 35!
The 'A CRISPR case-based TB detection system' is light, portable and can test over 1,500 samples in…
PTI
Wall Street just freaked out about a potential hiccup to a revolutionary gene editing technology - but it's not as bad as it seems
CRISPR Therapeutics chief scientific officer Dr. Bill Lundberg told Business Insider that the hope …
Lydia Ramsey
This startup wants to start using controversial CRISPR gene-editing technology in people by 2017
Many diseases, like Huntington's Disease and Cystic Fibrosis (CF), are caused by small tweaks, or m…
Lydia Ramsey
A revolutionary gene-editing technology is on track to be a $10 billion market by 2025
CRISPR, short for "clustered regularly interspaced short palindromic repeats," is a revolutionary t…
Lydia Ramsey
Scientists just got a step closer to treating incurable diseases using a revolutionary gene-editing tool
Getting to the point when we can safely and accurately edit genes to treat Huntington's disease wit…
Kevin Loria
Anyone could theoretically set up a lab able to genetically modify human embryos for less than $2,000
The Sun Yat-sen University group tried to edit the DNA of 86 embryos (all nonviable). Of the 71 tha…
Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years
Behind Tesla, the third largest holding in the ARKK ETF is CRISPR Therapeutics, a gene editing comp…